NCT02079766View on ClinicalTrials.gov

18F-AV-1451 and Florbetapir F 18 PET (Positron Emission Tomography) Imaging in Subjects at Risk for Chronic Traumatic Encephalopathy

PHASE2CompletedINTERVENTIONAL
Enrollment

41

Participants

Timeline

Start Date

June 30, 2014

Primary Completion Date

October 31, 2015

Study Completion Date

October 31, 2015

Conditions
Chronic Traumatic Encephalopathy
Interventions
DRUG

florbetapir F 18

370 megabecquerel (MBq) IV single-dose

DRUG

Flortaucipir F18

370 megabecquerel (MBq) IV single-dose

Trial Locations (2)

85006

Banner Alzheimer's Institute, Phoenix

02118

Boston University, Boston

Sponsors
All Listed Sponsors
lead

Avid Radiopharmaceuticals

INDUSTRY